Unifying Real-World Data and Advanced Analytics to Transform Life Sciences

Live Webinar

January 21, 2026

11:00 a.m. ET

AI-powered discovery for pharma and research

Oracle Life Sciences AI Data Platform

Pharma and research professionals are constantly seeking ways to harness the power of real-world data (RWD) to drive regulatory, clinical, and commercial breakthroughs. But access to high-value clinical RWD from leading health systems—and intuitive, AI-powered tools to fully leverage it—has been limited . . . until now.

With Oracle Life Sciences AI Data Platform, you can integrate, manage, and analyze vast real-world and proprietary datasets in a secure, cloud-native environment—empowering you to turn complexity into actionable insights using advanced AI.

In this webinar, you’ll gain insights on how to:

Access unparalleled clinical data: Tap into 230+ health systems and 123M+ de-identified patient records.
Leverage intuitive AI tools: Use generative AI and research agents tailored for life sciences.
Accelerate evidence generation: Harness deep, longitudinal clinical data for regulatory and real-world evidence.
Integrate insights effortlessly: Bring actionable data directly into your day-to-day operations.
Drive measurable impact: Achieve ROI with solutions that evolve with your organization

Don’t miss your chance to see what’s now possible with next-generation RWD and AI at your fingertips—register today and take the next step in transforming your research and development.

Featured speakers

Alexa Berk

Vice President, Real-World Evidence, Research Services

Close

Alexa Berk

Vice President, Real-World Evidence, Research Services

As Vice President of Real World Evidence (RWE) for Research Services, Alexandra (Alexa) Berk is the Global Head and domain leader for RWE at Oracle Life Sciences. In this role, Alexa leads an organization of nearly 200 cross-functional colleagues around the world with a shared goal of transforming drug development through the use of real world data and patient voices.
With over 20 years of experience in clinical and observational research, Alexa started her career in academia (Memorial Sloan Kettering Cancer Center) and pharma (Novartis). Alexa blends subject matter expertise and business acumen, drawing from her career progression from designing and conducting research studies to leading scientific teams, to an executive owning life sciences services P&Ls at two Fortune 100 companies.
In addition to leadership roles at large companies, Alexa has experience in building digital health and data businesses from the ground up. She was an early employee at Ciitizen (now Citizen Health), leading Ciitizen's go to market as a RWE platform for life sciences and was instrumental in driving their transformation from a Series A start-up to a $550M acquisition by medical genomics company Invitae in 2021. After the acquisition, Alexa took on a broader role at Invitae as the Medical Director for Digital Health and Data.
Immediately prior to joining Oracle Life Sciences, Alexa led Life Sciences Solutions at CVS Health as Associate Vice President and General Manager, after initially joining CVS Health as Chief Scientific Officer for RWE in CVS Clinical Trial Services in 2022. Alexa was promoted after just one year at CVS into the role of GM to re-establish and build out CVS' Life Sciences Solutions following the closure of Clinical Trial Services. Alexa's leadership rebuilt CVS Life Sciences Solutions from a full shutdown to a thriving organization which met its revenue goals in its first year after relaunching.
Alexa is a globally respected thought leader and professional speaker, frequently presenting on topics around RWD/RWE, health AI, and innovative, patient-centric, and equitable design in clinical trials. She has co-authored numerous manuscripts and abstracts in the scientific literature, with a focus on oncology and rare diseases and best practices in research methods. She is a graduate of Barnard College and the New School for Social Research.